Clinical trial
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy…
NCT00226473 · Dermatologic Cooperative Oncology Group, Other · Unknown status
Key facts
| NCT number | NCT00226473 |
|---|---|
| Title | Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma |
| Official title | Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy (CVD-Protocol) in the Second-Line Therapy of Distant Metastasized Malignant Melanoma |
| Lead sponsor | Dermatologic Cooperative Oncology Group, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metastatic Melanoma |
| Intervention type | Drug |
| Interventions | Cisplatin, Vindesine, Dacarbazine (drugs) |
| Enrollment | 200 |
| Start date | Sep 1, 2001 |
| Completion | Sep 1, 2005 |
| First posted | Sep 27, 2005 |
| Last update posted | Jun 21, 2006 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: